Christopher Gromisch
Pre-Doctoral Trainee
Boston University School of Medicine, Graduate Medical Sciences
Dept of Biochemistry






Development of a novel Antibody Drug Conjugate for the treatment of pancreatic cancer
08/01/2018 - 07/31/2021 (PI)
NIH/National Cancer Institute
5F30CA220843-02



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gromisch C, Qadan M, Machado MA, Liu K, Colson Y, Grinstaff MW. Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease. Cancer Res. 2020 Aug 15; 80(16):3179-3192.View Related Profiles. PMID: 32220831
     
  2. Wong CK, Gromisch C, Ozturk S, Papageorgis P, Abdolmaleky HM, Reinhard BM, Thiagalingam A, Thiagalingam S. MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer. Cancer Biol Ther. 2019; 20(8):1113-1120.View Related Profiles. PMID: 30922194
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 2 publications over 2 distinct years, with a maximum of 1 publications in 2019 and 2020

YearPublications
20191
20201

Contact for Mentoring:

700 Albany St Ctr for Adv Biomed Res
Boston MA 02118
Google Map


Gromisch's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department